Annual Report 2013
MD Anderson Cancer Center's 2012-2013 Annual Report highlights achievements and contributions of our faculty, staff, volunteers and donors in advancing the research, treatment and prevention of cancer. It also provides key financial and statistical data.
As a dermatologist and dermatopathologist, Kenneth Tsai, M.D., Ph.D., has set his sights on preventing squamous cell carcinoma — the second most common form of skin cancer in the United States.
People with inherited conditions that raise their risk of developing certain cancers, such as colon cancer, deal with a lot of anxiety that comes from uncertainty about their health. Hopefully, the work of Eduardo Vilar-Sanchez will one day alleviate that risk.
Paul Scheet, Ph.D., has a background in population genetics, which makes his role in the cancer prevention process a unique and important one.
Dallas’ Lyda Hill is determined to help solve “the mystery that is cancer.”
The Seed-funding Research Program helps scientists, researchers and clinicians across the institution launch innovative cancer prevention research projects.
An old blood test now offers new hope and possibility.
In 1983, Robert Bast Jr., M.D., and his colleagues published a seminal paper in the New England Journal of Medicine detailing his discovery of the protein CA-125 and its value in helping to predict if ovarian cancer might recur.
Imagine if oncologists around the world had access to the expertise of MD Anderson’s physicians. The standard of cancer care would be greatly improved, and lives would be saved.
Historically, research and patient care have been kept separate or “siloed.” Guillermo Garcia-Manero wants to change that.
When Mary Cates was told she had cancer, she didn’t flinch . . . either time.
Cancer is a genomic disease, and Harshad Mahadeshwar’s job is to decode its weaknesses.
There were 14.1 million new cancer cases worldwide in 2012.
MD Anderson system is bolstered by Graduate Medical Education’s homegrown experts
A year in, this duo of deans is racking up the accomplishments
The first drug to improve the survival of people with end-stage melanoma works because of what it doesn’t do: attack tumors directly.
By boosting the number of T cells in his patients, Patrick Hwu is watching their immune systems defeat cancer.
Marit Peterson may be genetically predisposed to melanoma, but the disease was no match for her and her team.
When immune system T cells that can’t kill a patient’s cancer get a shot at those same tumor cells in the lab, it’s another story altogether.
Every five years, the National Cancer Institute (NCI) evaluates the research programs and facilities at MD Anderson to determine if its status as a comprehensive cancer center will be renewed.
Treatments relying on T cells, a key component of the body’s immune system, have had significant success, but a new experimental method customizes naturally produced cells to sharpen their attack on cancer.
Generally speaking, hypermutation and DNA damage in a cell are bad things. That is, unless you’re talking about an immune system B cell.
The Nocturnal Program ensures a seamless transition from day to night for patients
When Lakeisha Day sees a patient in the wee hours, she knows she needs to make the most of their limited time together.
They’re known as the heart of MD Anderson. The 1,200 volunteers in blue jackets are true warriors in the battle to eliminate cancer.
Gloria Ayala walked into a hospital room and found a mother pacing while her daughter lay in bed. When Ayala was greeted with a big hug, she realized the experience was what being an MD Anderson volunteer was all about.
By exposing cancer cells, fluorescence makes surgeons’ jobs easier.
Treating cancer while preserving form and function.
Gift of gratitude boosts head and neck cancer research
Growing network of hospitals expands opportunities to end a global crisis
Previous IssuesView archives
Annual Report 2019
Back in the game after a brain tumor in the bladder
Annual Report 2018
Support goes beyond treatment
Annual Report 2016
75 years of Making Cancer History
Annual Report 2015
Annual Report 2014
Cancer can’t surprise us
Annual Report 2012
The time is now to educate
Annual Report 2011
From our president
Annual Report 2010
Many voices help tell the story
Annual Report 2009
From the President